Zobrazeno 1 - 10
of 210
pro vyhledávání: '"urothelial bladder carcinoma"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveTo evaluate the performance of a clinical-radiomics model based on contrast-enhanced computed tomography (CE-CT) in assessing human epidermal growth factor receptor 2 (HER2) status in urothelial bladder carcinoma (UBC).MethodsFrom January 20
Externí odkaz:
https://doaj.org/article/71132193651a46b18c9eb919c6846a1a
Autor:
Chen Zhang, Maoyu Wang, Yidie Ying, Fang Meng, Hongliang Gao, Shuxiong Zeng, Yasheng Zhu, Anwei Liu, Zhensheng Zhang, Chuanliang Xu
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12581-12592 (2023)
Abstract Background Kinesin family member 4A (KIF4A) is upregulated in a variety of cancers. However, its expression and potential downstream targets in urothelial bladder carcinoma (UBC) remain unclear. Methods Expression data of KIF4A in UBC and no
Externí odkaz:
https://doaj.org/article/c5b961df02014e63a1cd53c9f1884180
Autor:
Tianxi Yu, Huiying Tao, Wei Lv, Ning Liang, Xin Cui, Xiaolong Sui, Yu Pan, Shuang Wu, Chongjun Xiang, Yue Li, Yuchen Zeng, Conghui Li, Fei Wang, Peng Han, Wenting Wang, Guohua Yu, Chunhua Lin
Publikováno v:
Clinical and Translational Discovery, Vol 3, Iss 5, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/f2ae2a63d16e4e859293c1b43e9f2a75
Autor:
Reza Taherkhani, Fatemeh Farshadpour
Publikováno v:
Infectious Agents and Cancer, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background Bladder cancer is a challenging public health concern in South of Iran because of its high prevalence and the related medical expenses. Although the exact etiology of bladder cancer remains unknown, given the cell transforming abi
Externí odkaz:
https://doaj.org/article/b11560e9a9cc46689a5dcb9b7e48da97
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 553-559 (2022)
Bladder cancer is one of the main types of neoplasia affecting men, with the highest incidence reported toward the end of the seventh decade of life. Unlike other malignancies, bladder cancer is attributable to specific widely occurring carcinogenic
Externí odkaz:
https://doaj.org/article/4f169dc051ef4199852b83563e18f60a
Autor:
Tarq Aziz Toma
Publikováno v:
Zanco Journal of Medical Sciences, Vol 26, Iss 1, Pp 29-37 (2022)
Background and objective: Urothelial bladder carcinoma is a common malignancy but rarely occurs at young ages and can occur more frequently in the older group. The majority of bladder cancer consist of urothelial bladder carcinoma. This study aimed t
Externí odkaz:
https://doaj.org/article/d5e9a7f6392349ebb551d27aced8a9c1
Publikováno v:
Iranian Journal of Pathology, Vol 16, Iss 1, Pp 33-39 (2021)
Background & Objective: Prostate adenocarcinoma is the most common malignancy in males, and the urothelial bladder carcinoma is also prevalent. The histological characteristic of these two tumors is very similar in high-grade cases, and their differe
Externí odkaz:
https://doaj.org/article/5dfbd79d12354395a216946d85617c06
Autor:
Nazi Aghaalikhani, Nadereh Rashtchizadeh, Pejman Shadpour, Abdolamir Allameh, Marzieh Mahmoodi
Publikováno v:
Crescent Journal of Medical and Biological Sciences, Vol 8, Iss 1, Pp 42-47 (2021)
Objectives: Chronic inflammation in urothelial tissues can lead to DNA damage and cancer formation. Inflammatory reactions in bladder cancer (BC) probably depend on the stages and grades of tumors. The aim of this research was to find out if there is
Externí odkaz:
https://doaj.org/article/cba9e416a652478e87cbc5e417c6c590
Autor:
Harriet Evans, Brendan O’Sullivan, Frances Hughes, Kathryn Charles, Lee Robertson, Philippe Taniere, Salvador Diaz-Cano
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Immune checkpoint blockade (ICB) drugs are a novel, effective treatment for advanced urothelial carcinoma. Worldwide, several different ICB drugs are approved, each developed and clinically validated with a specific PD-L1 compound diagnostic assay. A
Externí odkaz:
https://doaj.org/article/93484c23c7454478b7dfca4deca2bb56
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 13, Pp 291-300 (2019)
Shiyu Mao,1,* Junfeng Zhang,1,* Yadong Guo,1,* Ziwei Zhang,1 Yuan Wu,2 Wentao Zhang,2 Longsheng Wang,1 Jiang Geng,1 Yang Yan,1 Xudong Yao1 1Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, PR China; 2Depa
Externí odkaz:
https://doaj.org/article/8a65072c0a1c4de0b934ddca74b2e583